About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
EPZM
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Epizyme GAAP EPS of -$0.21, revenue of $27.5M
- Ipsen extends tender offer date in Epizyme deal to get US antitrust clearance, required shares
- Hutchmed begins dosing in mid-stage study of tazemetostat in blood cancer subtype
- Epizyme stock soars 60% as Ipsen set to acquire the cancer drugmaker
- Hutchmed, Epizyme cancer drug Tazverik gets China's Hainan province health regulator nod
- Epizyme GAAP EPS of -$0.38 misses by $0.03, revenue of $8.69M misses by $1.33M
- Epizyme Q1 2022 Earnings Preview
- Epizyme chief medical officer Shefali Agarwal resigns
- Epizyme GAAP EPS of -$0.49 misses by $0.08, revenue of $11.6M misses by $8.82M
- Epizyme Q4 2021 Earnings Preview
- Epizyme equity offering pummels stock as shares down 40%
- Epizyme raises $85M capital via stock offering
- Epizyme announces proposed public offering of shares
- Epizyme multiple myeloma candidate granted FDA Orphan Drug Designation
- Epizyme jumps after product revenue shows strong sequential growth: Q4 Prelim
- Epizyme EPS misses by $0.11, misses on revenue
- Epizyme Q3 2021 Earnings Preview
- FDA grants Fast Track status to Epizyme's lymphoma treatment EZM0414
- Epizyme CEO Robert Bazemore steps down
- Epizyme EPS misses by $0.02, beats on revenue
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| November 9, 2021 | -0.64 / -0.48 | 5.2M / 8.65M | |
| August 9, 2021 | -0.63 / -0.6166 | 13.01M / 8.99M |
Beat! |
| May 10, 2021 | - / -0.63 | - / 9.47M | |
| February 23, 2021 | -0.65 / -0.581 | 8.38M / 6.55M |
Beat! |
| November 6, 2020 | -0.55 / -0.6041 | 3.57M / 5.89M | |
| August 4, 2020 | -0.58 / -0.62 | 2.47M / 5.08M | |
| May 4, 2020 | -0.51 / -0.75 | 1.35M / 3.28M | |
| February 24, 2020 | -0.59 / -0.5 | 4.29M / 3.7M |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4 | 1.490 | 1.520 |
1.590
|
1.460
|
2.39M | -3.25% | ||||
| Mar 3 | 1.540 | 1.670 |
1.765
|
1.510
|
2.45M | -6.67% | ||||
| Mar 2 | 1.650 | 1.590 |
1.710
|
1.510
|
1.68M | 3.77% | ||||
| Mar 1 | 1.590 | 1.250 |
1.620
|
1.230
|
2.86M | 6.71% | ||||
| Feb 28 | 1.490 | 1.470 |
1.490
|
1.390
|
3.96M | 0.68% | ||||
| Feb 25 | 1.480 | 1.490 |
1.530
|
1.410
|
1.54M | -1.99% | ||||
| Feb 24 | 1.510 | 1.400 |
1.510
|
1.305
|
3.37M | 6.34% | ||||
| Feb 23 | 1.420 | 1.550 |
1.550
|
1.410
|
1.92M | -8.97% | ||||
| Feb 22 | 1.560 | 1.560 |
1.670
|
1.520
|
3.97M | 1.30% | ||||
| Feb 18 | 1.540 | 1.480 |
1.570
|
1.420
|
2.97M | 4.76% | ||||
| Feb 17 | 1.470 | 1.570 |
1.600
|
1.450
|
1.95M | -8.7% | ||||
| Feb 16 | 1.610 | 1.580 |
1.630
|
1.530
|
1.47M | -0.62% | ||||
| Feb 15 | 1.620 | 1.570 |
1.670
|
1.550
|
3.16M | 7.28% | ||||
| Feb 14 | 1.510 | 1.650 |
1.650
|
1.510
|
3.42M | -7.36% | ||||
| Feb 11 | 1.630 | 1.720 |
1.720
|
1.560
|
2.27M | -4.68% | ||||
| Feb 10 | 1.710 | 1.730 |
1.810
|
1.620
|
2.70M | -1.16% | ||||
| Feb 9 | 1.730 | 1.710 |
1.806
|
1.710
|
5.13M | 2.98% | ||||
| Feb 8 | 1.680 | 1.640 |
1.680
|
1.570
|
1.97M | 1.20% | ||||
| Feb 7 | 1.660 | 1.500 |
1.695
|
1.430
|
3.10M | 11.41% | ||||